Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

5.39
Delayed Data
As of Oct 20
 -0.04 / -0.74%
Today’s Change
4.93
Today|||52-Week Range
24.09
-70.09%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues110.5M123.9M90.4M100.5M
 
 
 
 
 
Cost of Goods Sold19.6M22.0M17.2M19.1M
 
 
 
 
 
Depreciation And Amortization27.7M26.4M26.3M26.3M
 
 
 
 
 
 
Operating ExpensesGross Income63.2M75.5M46.9M55.0M
 
 
 
 
 
General Expenses61.9M57.6M58.6M56.8M
 
 
 
 
 
Research And Development10.4M9.2M5.1M5.6M
 
 
 
 
 
Total Operating Expenses109.2M106.0M102.1M102.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.3M17.9M-11.7M-1.8M
 
 
 
 
 
Extraordinary Credit0.000.005.0M1.1M
 
 
 
Extraordinary Charge-686.0K0.00-531.0K-9.1M
 
 
 
 
Interest Expense On Debt19.7M20.5M19.6M17.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.9M-2.5M-26.5M-26.9M
 
 
 
 
 
Income Taxes-6.0M-41.9M-202.0K-249.0K
 
 
 
 
 
Net Income-12.9M-44.4M-26.7M-26.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS61.4M61.7M62.1M62.5M
 
 
 
 
 
Shares To Calculate EPS Diluted61.4M61.7M62.1M62.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.21-$0.72-$0.43-$0.43
 
 
 
 
 
EPS Diluted-$0.21-$0.72-$0.43-$0.43